See also this year's filing and all EDGAR filings for this company.
PDF Report 0001622229_2019_Cogent_Biosciences_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001622229, Cogent Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 81,002,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,251,000 |
| 3 | remainder_Assets | 1,674,000 |
| 4 | LiabilitiesCurrent | 24,945,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 748,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,454,000 |
| 9 | ResearchAndDevelopmentExpense | 38,285,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 9,734,000 |
| 12 | remainder_NetIncome | 1,473,000 |
| 13 | remainder_ComprehensiveNetIncome | 4,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 85,927,000 |
| 1 | Liabilities | 25,693,000 |
| 2 | Expenses | 45,739,000 |
| 3 | Revenues | 9,734,000 |
| 4 | StockholdersEquity | 60,234,000 |
| 5 | NetIncome | -34,532,000 |
| 6 | ComprehensiveNetIncome | -34,530,000 |
| 7 | BaseVar | 84,285,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.73 |
| 9 | EconomicCapitalRatio | 2.84 |
Edgar->Model Mapping
Feature Distribution
